Business Wire

Sandvine: Our Next Chapter as a Market Leader for Technology Solutions

19.9.2024 18:26:00 CEST | Business Wire | Press release

Share

With new owners, a commitment to new leadership, and reoriented business model, today we announce the next chapter of Sandvine as a technology solution leader for democracies.

Our technology facilitates internet access for hundreds of millions of people around the globe. We work with the world’s largest internet service providers to classify network traffic, enhance network connectivity, and counter threats to network security. Our mission is to help people work, learn, entertain and communicate. In response to concerns regarding the misuse of our technology by foreign governments, we made a commitment to new ownership, leadership, and business strategy. In the last several months, we have committed to significant changes to our governance and business model in consultation with the U.S. Department of Commerce, the U.S. Department of State, and other key members of the U.S. government.

These transformative changes include:

  • Focusing Our Global Operations to Democracies in Support of Internet Freedom and Digital Rights. We believe that the best way to consistently and reliably prevent, detect, and deter misuse of our technology is to exit jurisdictions that lack a consistent, demonstrable commitment to internet freedom and strong rule of law protections. After conducting a full review of our business in jurisdictions that lack such commitments, we will no longer operate in non-democratic countries or countries where the threat to digital rights is too high.1 Accordingly, we have already exited 32 countries and are in the process of exiting an additional 24 countries, with an end-of-service date of March 31, 2025 (for Government of Egypt customers) and December 31, 2025 (for remaining Egyptian customers and all other identified countries).2 We are not just taking this new approach because it’s the right thing to do—we are implementing a viable business strategy that positions us to remain a technological leader and to provide indispensable service for our customers.
  • Dedicating 1% of All Profits to Protecting Digital Rights. We are committed to being a leader within our industry in the important fight to protect internet freedom and digital rights. In addition to our new democracy-only go-to-market plan, starting in 2025 we will donate 1% of future profits to organizations dedicated to protecting internet freedom and remediating instances of human rights and digital abuse. We should all do our part to ensure that all can enjoy an open and democratized internet, and hope our commitment inspires our peers to do the same.
  • Adding Digital Rights Expertise to Our Team. To guide our new mission and anticipate emerging human rights risks, we will retain and consult with outside advisors with deep expertise in understanding the global risks to digital rights. This initiative includes adding a senior advisor who will report directly to the Board of Directors to counsel on emerging risks and help prevent future product misuse, as well as help us better engage relevant non-governmental organizations and civil society to facilitate the protection of basic freedoms on the internet. This senior advisor will also report to the Board’s newly created Human Rights Subcommittee, which will exercise oversight over the company’s new governance and compliance controls, including a structure to prevent human rights and ensure export control compliance.
  • New Engagement with Civil Society. We are committed to having better relationships and consultations with civil society and affected stakeholders, both to understand how we can support digital rights and to understand the risks of future geopolitical and human rights risks. We will seek more engagement with human rights groups and other stakeholders, including those recommended by the U.S. Department of State, prior to expanding business operations to new jurisdictions.
  • Adopting New Controls for Ongoing Business Operations. For countries where we plan to remain, we will monitor for reports and signs of product misuse by customers through a new program that prioritizes human rights due diligence (“HRDD”).3 Relevant business decisions will undergo scrutiny through a Business Ethics Committee (“BEC”), which will seek input from outside policy advisors, as well as outside counsel who have significant prior government experience combatting human rights abuses. The BEC will identify and assess countries and territories with a history of blocking or censoring websites or social media platforms or using spyware, data analytics, and other forms of internet restrictions or surveillance to commit human rights abuses and infringe upon the rule of law.
  • New Owners and Leadership. This summer, a group of institutional investors committed to driving the evolution of our company forward replaced prior ownership. Our new owners have already appointed a new Board that, aided by a human rights advisor and other resources, can oversee the company’s new direction. Likewise, with this chapter successfully behind us, our current CEO has announced his intention to step down. The company has initiated a search and selection process for a new CEO with human-rights focused leadership who will continue the company’s progress toward our new democratically focused business model.
  • New Name. Starting in2025,we will operate under a new name that reflects our leadership in protecting digital rights. While we will not ignore what has happened in the past, we are eager for a new brand that customers and the public will come to know as a leader in the way companies can shape their business and governance to promote a free, reliable, and accessible internet.

The misuse of deep packet inspection technology is an international problem that threatens free and fair elections, basic human rights, and other digital freedoms we believe are inalienable. Over the last several years, there have been instances where we believe our products were misused by foreign governments in order to infringe on civil liberties and other rights. In the past, we responded through different legal and technological methods available to us. Unfortunately, we have concluded that such steps are not enough, and what is required is a more dramatic shift in the markets in which we operate and in the way that we do business. We recognize this decision may be disruptive, and we are committed to exiting markets in a way that maintains internet connectivity to the millions of subscribers our customers serve.

We acknowledge past misuse of Sandvine’s products, as well as the fact that the company’s response to past reports of misuse was insufficient. We also unequivocally condemn any misuse of our products to facilitate repression, limit freedom of expression, restrict freedom of association, monitor journalists and political dissidents, and disrupt democratic elections. In that vein, and with the changes outlined today, we are now well positioned to be an industry leader that forcefully pushes back on authoritarian governmental use of technology to undermine democratic norms and abuse basic human rights.

As we embark on this new chapter as a technology solution leader for democracies, we are especially thankful to our customers and business partners for their continued support and steadfast fidelity to our purpose. We are, and will remain, committed to improve because we believe access to digital communication and its benefits bolsters the values and interests of democracy.

____________________
1 This decision was based on a review of our operations using a variety of government and external references, including the U.S. Department of State Country Reports on Human Rights Practices, the Reporters Without Borders’ 2023 World Press Freedom Index, and Freedom House’s 2024 Internet Freedom Scores. We made the decision to exit all countries categorized as “non-democratic” in the Economist Intelligence Unit’s 2023 Democracy Index, which is available here.
2 In the interim period before exiting these jurisdictions, Sandvine will maintain contractual authority to act on violations of the end-user license agreement.
3 Our new HRDD program will look to implement enhanced measures and transparency in line with the U.S. State Department’s Guidance on Implementing the UN Guiding Principles for Transactions Linked to Foreign Government End-Users for Products or Services with Surveillance Capabilities.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240919441171/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye